GHK-Cu

GHK-Cu

notion image
 
Discovered in 1973 by Loren Pickart, a biochemist at UCSF who reportedly used it on himself daily, GHK-Cu is a peptide your body naturally produces that declines significantly with age. It delivers copper into cells, and signals cells to behave more like younger ones.
More specifically, it stimulates collagen production and remodeling, reduces inflammation, accelerates wound healing, and also appears to support neuroprotection and tissue repair more broadly.
Tighter, firmer, more elastic skin, less wrinkles and better hair follicles. (and it actually really work)

Deep-dive

Plasma levels decline significantly with age, at age 20 there’s about 200 ng/mL vs at age 60 there’s about 80 ng/mL. And if you’re a young buck today, it’s fair to assume those level will be even worse for you with age with all shit we’re exposed to disrupting our copper metabolism.
GHK-CU is a simple peptide with only 3 amino-acids: glycine (G), histidine (H), lysine (K) which have a unique ability to bind a copper(II) ion (Cu²⁺).
This peptide is unique in it’s ability to transport the copper ion into the cell which was the expected effect, but later discovered the GHK peptide was doing its own signalling on top of that. There’s also some thought that it plays a role in gene expression and most commonly known to stimulate collagen and elastin production and re-modeling.
According to a 2018 review, GHK-Cu has been shown to:
  • Tighten, firm, and improve elasticity of aging skin
  • Reduce fine lines, wrinkles, and photo damage
  • Smooth rough skin and reduce hyperpigmentation
  • Repair skin barrier proteins
  • Stimulate wound healing and protect against UV radiation
  • Reduce inflammation and free radical damage
  • Increase hair growth, thickness, and follicle size
Originally discovered for liver regeneration. Pickart noticed that when old liver tissue was exposed to young blood plasma, it started producing proteins like younger tissue. GHK was the molecule responsible.
It's now understood that GHK-Cu works through two simultaneous mechanisms: the copper it delivers into cells, and the GHK peptide itself acting as a direct signalling molecule. The GHK peptide alone has been shown to influence over 4,000 human genes:
  • Collagen and elastin genes — directly turns up the genes that tell fibroblasts to produce more collagen, binds directly to fibroblasts and activates them independently of gene expression, and restores replicative vitality to fibroblasts that have been damaged or aged, essentially making old fibroblasts behave like younger ones again. The copper delivered simultaneously activates lysyl oxidase — the enzyme that organises and cross-links new collagen fibres into proper structure. So the peptide clears old collagen via MMPs, stimulates new production, and the copper ensures what gets laid down is properly structured and strong. This is the most well documented effect.
  • Matrix metalloproteinases (MMPs): GHK regulates both the enzymes that break down old and damaged collagen AND their inhibitors (TIMPs), creating a balanced remodeling cycle. Rather than just producing more collagen on top of old damaged collagen, the peptide programs the cell to clear out the old before laying down the new.
  • Antioxidant genes — upregulates superoxide dismutase (SOD) and other antioxidant enzymes, meaning cells become better at neutralising free radicals and oxidative damage. The copper delivered simultaneously activates SOD directly, SOD requires copper to function, hitting oxidative stress from both the gene expression side and the raw materials side simultaneously.
  • Anti-inflammatory genes: suppresses TNF-α and IL-6, two of the main drivers of chronic inflammation
  • DNA repair and cancer-related genes — according to a 2014 study, GHK activated 47 DNA repair genes and 10 caspase genes, which trigger programmed cell death in damaged or malfunctioning cells. In a separate finding, out of 1,309 bioactive molecules tested, GHK was one of only two that reversed the expression of 70% of genes associated with aggressive metastatic colon cancer.
  • Nerve growth factor (NGF) genes — GHK directly upregulates NGF and the broader neurotrophin family, promoting neuron survival, nerve repair, and regeneration. Declining neurotrophin levels are directly associated with Alzheimer's and Parkinson's. The copper delivered adds a separate layer of neuroprotection, the brain is one of the most copper-dependent organs in the body. Copper powers SOD antioxidant enzymes in neurons, supports myelin formation around nerve fibres, enables dopamine and noradrenaline synthesis, and supports energy production in neurons. A diet chronically low in copper increases the risk of neurodegenerative changes independently of GHK.
  • Fibrinogen genes: suppresses fibrinogen production by 475%, reducing cardiovascular risk
  • Pro-fibrotic genes: turns down genes that cause excessive scarring and fibrosis, and upregulates decorin, a proteoglycan that organises collagen structure and has anti-tumour properties. Notably helped normalise damaged fibroblasts in COPD lung tissue.
  • Anti-pain genes: GHK upregulates opioid receptor gene expression, producing more receptors on neuron surfaces and increasing sensitivity to the body's own natural painkillers. It also upregulates potassium channel genes, making neurons more prone to hyperpolarisation and harder to fire. Separately, one study found that low copper dropped plasma opiate levels by 80% — restored immediately when copper was replaced — suggesting GHK's copper delivery also helps maintain the body's endogenous pain dampening system.
  • Anti-anxiety and anti-aggression: in rat studies, GHK reduced the freeze response to threat and produced a 5-fold reduction in stress-induced attacks, both within 12 minutes of injection, suggesting a direct neurological effect rather than a slow hormonal shift. GHK appears to influence GABA-related gene expression, upregulating genes associated with inhibitory signalling, though the exact mechanism in humans hasn't been fully established. Copper is also required for the synthesis of noradrenaline and dopamine — so GHK's copper delivery likely supports the neurotransmitter balance underlying mood and stress regulation as well.
  • Stem cell genes: GHK upregulates p63 and integrin expression in epidermal basal cells, the stem-like cells at the base of the outer skin layer that continuously divide to renew skin. p63 is the protein that tells these cells to keep dividing rather than differentiating and dying. Integrins anchor them in their correct position in the basal layer. Higher expression of both causes cells to physically change shape, becoming more cuboidal — characteristic of younger, more active stem cells.
  • Glycosaminoglycan (GAGs) synthesis genes: GHK upregulates production of molecules like hyaluronic acid that keep skin hydrated and joints lubricated
GHK is part of a protein in many tissues that when it sustains tissue damage the GHK is released to stimulate the healing of that tissue.
According to a 2021 review, GHK-Cu has also been shown to re-establish blood flow into damaged tissue through angiogenesis (the creation of new blood vessels), vasodilation, and anticoagulation. It also increases the expression of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF).

Dosage:

  • 1-2 mg daily subcutaneous injections.
  • Typical cycle: 8–12 weeks on, 4 weeks off

Here’s what you can expect:

Results of GHK-Cu are pretty gradual and you won’t notice anything right away. After about two weeks to a month you’ll start noticing subtle changes in skin like firmness, texture, and hydration followed by a reduction in fine lines and overall skin quality. At month 2-3 you’ll notice significant improvements and might also notice changes in hair quality, faster healing of cuts, bruises, and general tissue damage, as-well as reduced joint pain and general inflammation.

Side effects & risks:

  • Most people will experience some degree of injection site reactions, redness, swelling, tenderness, itching, bruising, and occasionally a small lump under the skin that may persist for a few days. This is partly because when GHK-Cu is injected, free copper can temporarily separate from the peptide before rebinding in tissues, triggering a localised inflammatory response
  • GHK-Cu contains copper, there is a hypothetical risk of copper toxicity. 2mg of GHK-Cu contains 160–320 mcg of elemental copper per injection. The upper intake level is considered 5-10mg/day, so this is low risk. Symptoms include abdominal pain, vomiting, chest pain, chills, fever, weakness, tremors, and a metallic taste in the mouth. Metallic taste in your mouth is usually the first sign, followed by nausea, abdominal discomfort, and fatigue.
  • Receptor desensitisation (hence we cycle this)
  • Active cancer — avoid. The same angiogenesis and cell-growth mechanisms that make GHK-Cu effective for healing could theoretically support tumor growth.
  • Wilson's disease (rare genetic disorder where the body can't properly excrete copper)avoid completely.

🩸

Blood markers

Serum copper — baseline before starting to confirm levels aren't already elevated. Recheck at end of cycle to check for accumulation.
Ceruloplasmin — your body's main copper transport protein. Low levels can indicate Wilson's disease, which is the main contraindication. Check at baseline.
Full lipid panel (LDL, HDL, triglycerides) — general baseline and to track any downstream benefits from GHK-Cu's anti-inflammatory effects. Check at baseline, recheck at end of cycle.
ALT + AST (liver enzymes) — the liver is central to copper metabolism. Any impairment affects how copper is processed and excreted. Check at baseline.
For a client, serum copper and a liver panel before starting is sufficient. Ceruloplasmin only if there's any family history of copper metabolism issues or unexplained liver symptoms.